STUDY ON REDUCING HYPOGLYCEMIA IN HEMODIALYSIS PATIENTS USING CGM AND ITS IMPACT ON COGNITIVE FUNCTION AND CARDIOVASCULAR EVENTS

MITIGATING HYPOGLYCEMIA RISKS IN HEMODIALYSIS PATIENTS USING CONTINOUS GLUCOSE MONITORING AND ITS IMPACT ON COGNITIVE FUNCTION,INTRADIALYTIC COMPLICATIONS AND CARDIOVASCULAR EVENTS - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/078445

Enrollment

Registered

2024-12-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: N184- Chronic kidney disease, stage 4 (severe)

Interventions

Intervention1: CONTINOUS GLUCOSE MONITORING: HEMODIALYSIS PATIENTS WHO ARE DIABETIC AND ON INSULIN AND PATIENT IS FOLLOWED UP FOR 1 YEAR Control Intervention1: HEMODIALYSIS PATIENTS: HEMODIALYSIS PATI

Eligibility

Inclusion criteria

Inclusion criteria: PATIENT WITH DIABETIC NEPHROPATHY ON HEMODIALYSIS WITH MINIMUM TWICE DIALYSIS WEEKLY

Exclusion criteria

Exclusion criteria: PATIENT TAKING STEROIDS PATIENT WITH PRE EXISTING PSYCHIATRIC ILLNESS

Design outcomes

Primary

Measure	Time frame
TO REDUCE THE RISK OF HYPOGLYCEMIA IN HEMODIALYSIS PATIENTS USING CGMTimepoint: 1 YEAR	—

Secondary

Measure	Time frame
EVALUATE THE FREQUENCY,SEVERITY AND PATTERN OF HYPOGLYCEMIC EPISODES IN DIALYSIS PATIENTS THROUGH CGM DATA AND APPROPRIATE INTERVENTIONS IF ANYTimepoint: 1 YEAR	—

Countries

India

Contacts

Public ContactDR SUNIL ANTONY

BELIEVERS CHURCH MEDICAL COLLEGE

drsunilantony@gmail.com9497854565

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026